¿ÀÅäÀÎÁ§ÅÍ ½ÃÀå : Á¦Ç° À¯Çüº°, ÀûÀÀÁõº°, ÃÖÁ¾»ç¿ëÀÚº°, ±¹°¡º°, Áö¿ªº° - »ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð, ½ÃÀå Á¡À¯À², ¿¹Ãø(2024-2032³â)
Auto-Injectors Market, By Product Type, By Indication, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
»óǰÄÚµå : 1605772
¸®¼­Ä¡»ç : AnalystView Market Insights
¹ßÇàÀÏ : 2024³â 11¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 398 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,250 £Ü 4,612,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 4,650 £Ü 6,598,000
PDF (5 User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,650 £Ü 8,017,000
PDF & Excel (Enterprise User License) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» ¸ðµç »ç¿ëÀÚ°¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy&Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

º¸°í¼­ ÇÏÀ̶óÀÌÆ®

2023³â ¿ÀÅäÀÎÁ§ÅÍ ½ÃÀå ±Ô¸ð´Â 112Á¶ 1,232¾ï 1,000¸¸ ´Þ·¯, 2024³âºÎÅÍ 2032³â±îÁö ¿¬Æò±Õ 12.5%·Î È®´ëµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¿ÀÅäÀÎÁ§ÅÍ ½ÃÀå - ½ÃÀå ¿ªÇÐ

¸¸¼ºÁúȯÀÇ Áõ°¡

¿ÀÅäÀÎÁ§ÅÍ ½ÃÀåÀº ´ç´¢º´, ·ù¸¶Æ¼½º °üÀý¿°, ¾Æ³ªÇʶô½Ã½º µî ¾à¹° ÀÚ°¡ Åõ¿©°¡ ÀÚÁÖ ÇÊ¿äÇÑ ¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡¿Í °°Àº ¸î °¡Áö Áß¿äÇÑ ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ¾à¹°Àü´Þ ±â¼úÀÇ ¹ßÀü, ÀçÅà ÀÇ·áÀÇ Ã¤Åà Áõ°¡, Æí¸®ÇÏ°í °íÅ뽺·´Áö ¾ÊÀº ÁÖ»ç ¹æ¹ý¿¡ ´ëÇÑ ¿ä±¸°¡ ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ȯÀÚ Á᫐ ¼Ö·ç¼Ç¿¡ ´ëÇÑ Á߿伺ÀÌ °­Á¶µÇ°í ÷´Ü ¿ÀÅäÀÎÁ§ÅÍ ÀåÄ¡¿¡ ´ëÇÑ ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎÀº ½ÃÀå È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¸ÂÃãÇü ÀÇ·á·ÎÀÇ Àüȯ°ú »ý¹°ÇÐÀû Á¦Á¦¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁü¿¡ µû¶ó ÇコÄÉ¾î ºÐ¾ßÀÇ ¿ÀÅäÀÎÁ§ÅÍ ¼ö¿ä Áõ°¡¸¦ µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù.

¿ÀÅäÀÎÁ§ÅÍ ½ÃÀå - ÁÖ¿ä ÀλçÀÌÆ®

´ç»çÀÇ ¸®¼­Ä¡ ºÐ¼®°¡µéÀÇ ºÐ¼®¿¡ µû¸£¸é, ¼¼°è ½ÃÀåÀº ¿¹Ãø ±â°£(2024-2032³â) µ¿¾È ¿¬Æò±Õ ¾à 12.5%ÀÇ CAGR·Î ¸Å³â ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Á¦Ç° À¯Çüº°·Î´Â ÀÏȸ¿ë ¿ÀÅäÀÎÁ§ÅͰ¡ 2023³â °¡Àå Å« ½ÃÀå Á¡À¯À²À» º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµÆ½À´Ï´Ù.

ÀûÀÀÁõº°·Î´Â 2023³â ·ù¸¶Æ¼½º °üÀý¿°ÀÌ ÁÖ¿ä À¯ÇüÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù.

Áö¿ªº°·Î´Â ºÏ¹Ì°¡ 2023³â ¸ÅÃâÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù.

¿ÀÅäÀÎÁ§ÅÍ ½ÃÀå - ¼¼ºÐÈ­ ºÐ¼®:

¼¼°è ¿ÀÅäÀÎÁ§ÅÍ ½ÃÀåÀº Á¦Ç° À¯Çü, ÀûÀÀÁõ, ÃÖÁ¾»ç¿ëÀÚ ¹× Áö¿ªÀ» ±âÁØÀ¸·Î ¼¼ºÐÈ­µË´Ï´Ù. ¿ÀÅäÀÎÁ§ÅÍ ½ÃÀåÀº ÁÖ·Î Á¦Ç° À¯Çü¿¡ µû¶ó ÀÏȸ¿ë ¿ÀÅäÀÎÁ§ÅÍ¿Í Àç»ç¿ë °¡´ÉÇÑ ¿ÀÅäÀÎÁ§ÅÍÀÇ µÎ °¡Áö ºÎ¹®À¸·Î ³ª´¹´Ï´Ù. ÀÏȸ¿ë ¿ÀÅäÀÎÁ§ÅÍ´Â ÀÏȸ¿ëÀ¸·Î ¼³°èµÇ¾úÀ¸¸ç ÀϹÝÀûÀ¸·Î ÀÀ±Þ Ä¡·á°¡ ÇÊ¿äÇÑ »óÅ ¶Ç´Â ºñ¿ë È¿À²¼ºÀÌ ¿ì¼±½ÃµÇ´Â °æ¿ì¿¡ ¼±È£µË´Ï´Ù. ¹Ý¸é, Àç»ç¿ë °¡´ÉÇÑ ¿ÀÅäÀÎÁ§ÅÍ´Â ¿©·¯ ¹ø »ç¿ëÇÒ ¼ö ÀÖµµ·Ï ¼³°èµÇ¾úÀ¸¸ç, ¸¸¼ºÁúȯÀ¸·Î Áö¼ÓÀûÀÎ ¾à¹° Åõ¿©°¡ ÇÊ¿äÇÑ È¯ÀÚ¿¡°Ô ÀÚÁÖ »ç¿ëµË´Ï´Ù. ÀÏȸ¿ë ¿ÀÅäÀÎÁ§ÅÍ ºÎ¹®Àº ÆíÀǼº, »ç¿ëÀÇ ¿ëÀ̼º, ¾Æ³ªÇʶô½Ã½º ¿¡Çdz×ÇÁ¸°°ú °°Àº ÀÀ±Þ Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡·Î ÀÎÇØ ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù.

¿ÀÅäÀÎÁ§ÅÍ ½ÃÀåÀº ·ù¸¶Æ¼½º °üÀý¿°, ´Ù¹ß¼º °æÈ­Áõ, ´ç´¢º´, ¾Æ³ªÇʶô½Ã½º, ±âŸ Ä¡·á µî ÀûÀÀÁõ¿¡ µû¶ó ¼¼ºÐÈ­µÇ¾î ÀÖ½À´Ï´Ù. ÀÌ Áß ·ù¸¶Æ¼½º °üÀý¿° ºÐ¾ß´Â ·ù¸¶Æ¼½º ÁúȯÀÇ À¯º´·ü Áõ°¡¿Í ¿ÀÅäÀÎÁ§Å͸¦ ÅëÇØ Åõ¿©µÇ´Â »ý¹°ÇÐÀû Á¦Á¦ÀÇ Ä¡·á È¿°ú·Î ÀÎÇØ ¾ÐµµÀûÀÎ Á¡À¯À²À» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ´Ù¹ß¼º °æÈ­Áõµµ Å« ºñÁßÀ» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÀåÄ¡¸¦ »ç¿ëÇϸé ȯÀÚ°¡ Áý¿¡¼­ Ä¡·á¸¦ ¹ÞÀ» ¼ö ÀÖ¾î ÆíÀǼºÀÌ Çâ»óµÇ°í º´¿ø ¹æ¹® Ƚ¼ö°¡ ÁÙ¾îµé±â ¶§¹®ÀÔ´Ï´Ù. ´ç´¢º´ ºÐ¾ß´Â Àν¶¸° ÀÇÁ¸¼º ȯÀÚÀÇ Áõ°¡·Î ÀÎÇØ ºü¸£°Ô ¼ºÀåÇϰí ÀÖÀ¸¸ç, ¾Æ³ªÇʶô½Ã½º´Â ƯÈ÷ ÀÀ±Þ »óȲ¿¡¼­ Áß¿äÇÑ »ç¿ë »ç·Ê·Î ³²¾ÆÀÖ½À´Ï´Ù. Àü¹ÝÀûÀ¸·Î ȯÀÚ Áß½ÉÀÇ ¼Ö·ç¼Ç¿¡ ÃÊÁ¡À» ¸ÂÃá ½ÃÀåÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù.

½ÃÀåÀº ÃÖÁ¾ ¿ëµµ¿¡ µû¶ó ÀçÅà ¿ä¾ç½Ã¼³, º´¿ø ¹× Áø·á¼Ò, ¿Ü·¡ ¼ö¼ú¼¾ÅÍ·Î ±¸ºÐµË´Ï´Ù. Àç°¡ ¿ä¾ç½Ã¼³ÀÌ ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖ½À´Ï´Ù. ¿ÀÅäÀÎÁ§Åʹ ȯÀÚ°¡ ½º½º·Î ¾ÈÀüÇÏ°í °£ÆíÇÏ°Ô ¾à¹°À» Åõ¿©ÇÒ ¼ö Àֱ⠶§¹®¿¡ ÀçÅà ¿ä¾ç ÇöÀå¿¡¼­ Àα⸦ ²ø°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÆíÀǼºÀº ¸¸¼ºÁúȯÀ» °ü¸®Çϴ ȯÀڵ鿡°Ô ´õ Ä£¼÷Çϰí È¿À²ÀûÀÎ Ä¡·á¸¦ Á¦°øÇϱ⠶§¹®¿¡ ÀÇ·áÁøÀ» ÀÚÁÖ ¹æ¹®ÇÒ Çʿ伺À» ÁÙ¿©ÁÝ´Ï´Ù. ÀçÅà ÀÇ·á ºÐ¾ß¿¡¼­ ÀÌ·¯ÇÑ ±â±âÀÇ µîÀåÀº ÀÌ ºÐ¾ßÀÇ ±Þ°ÝÇÑ ¼ºÀå¿¡ ±â¿©ÇÏ´Â Áß¿äÇÑ ¿äÀÎÀÔ´Ï´Ù.

¿ÀÅäÀÎÁ§ÅÍ ½ÃÀå - Áö¸®Àû ÀλçÀÌÆ®

Áö¿ªº°·Î´Â ºÏ¹Ì, ¶óƾ¾Æ¸Þ¸®Ä«, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«¿¡ ºÐÆ÷µÇ¾î ÀÖÀ¸¸ç, 2023³â ºÏ¹Ì°¡ ½ÃÀåÀ» ÁÖµµÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ÁÖ·Î ´ç´¢º´, ¾Æ³ªÇʶô½Ã½º, ·ù¸¶Æ¼½º °üÀý¿° µî ¸¸¼ºÁúȯÀÇ ³ôÀº À¯º´·ü·Î ÀÎÇØ ºÏ¹Ì°¡ ½ÃÀåÀ» ÁÖµµÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ Áö¿ªÀº źźÇÑ ÀÇ·á ÀÎÇÁ¶ó, ¾à¹° ÀÚ°¡ Åõ¿©¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, ¾à¹°Àü´Þ ±â¼úÀÇ Áö¼ÓÀûÀÎ ¹ßÀü µîÀÇ ÇýÅÃÀ» ´©¸®°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÁÖ¿ä ½ÃÀå ÁøÀÔ ±â¾÷µéÀÇ R&D ÅõÀÚ, Á¤ºÎ Áö¿ø Á¤Ã¥, ¸·´ëÇÑ ÀÇ·áºñ ÁöÃâÀÌ ½ÃÀå È®´ëÀÇ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀÌ º¹ÇÕÀûÀ¸·Î ÀÛ¿ëÇÏ¿© ºÏ¹Ì´Â ¼¼°è ¿ÀÅäÀÎÁ§ÅÍ ½ÃÀå¿¡¼­ ¼±µµÀûÀÎ À§Ä¡¸¦ Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. À¯·´Àº °í·ÉÈ­¿Í ÀÀ±Þ Ä¡·á ¼Ö·ç¼Ç¿¡ ´ëÇÑ ³ôÀº ¼ö¿ä¿¡ ÈûÀÔ¾î ²ÙÁØÇÑ ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀº ÀÇ·á ÀÎÇÁ¶óÀÇ ¼ºÀå, ÀνÄÀÇ Áõ°¡, »ýȰ½À°üº´ÀÇ È®»ê¿¡ ÈûÀÔ¾î ÁÖ¿ä ½ÃÀåÀ¸·Î ºÎ»óÇϰí ÀÖ½À´Ï´Ù. ¶óƾ¾Æ¸Þ¸®Ä«¿Í Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«´Â ÀÇ·á Á¢±Ù¼ºÀÌ °­È­µÇ¸é¼­ ¾ÈÁ¤ÀûÀÎ ¼ºÀå¼¼¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¿ÀÅäÀÎÁ§ÅÍ ½ÃÀå - °æÀï »óȲ:

¿ÀÅäÀÎÁ§ÅÍ ½ÃÀåÀº Mylan, Becton Dickinson, Amgen, Teva Pharmaceuticals µî ÁÖ¿ä ¾÷üµéÀÇ Ä¡¿­ÇÑ °æÀïÀÌ Æ¯Â¡ÀÔ´Ï´Ù. ÀÌµé ±â¾÷Àº ·ù¸¶Æ¼½º °üÀý¿°, ´Ù¹ß¼º °æÈ­Áõ, ¾Æ³ªÇʶô½Ã½º µîÀÇ Áõ»ó¿¡ ´ëÀÀÇÏ´Â ´Ù¾çÇÑ Á¦Ç°À» Á¦°øÇϰí ÀÖ½À´Ï´Ù. ÀÌ ½ÃÀåÀº ¾ÈÀü ±â´ÉÀ» °­È­ÇÑ »ç¿ëÇϱ⠽¬¿î µð¹ÙÀ̽ºÀÇ °³¹ß µî ±â¼ú ¹ßÀüÀÇ ¿µÇâÀ» ¹Þ°í ÀÖ½À´Ï´Ù. ƯÈ÷ ¿¡Çdz×ÇÁ¸° ¿ÀÅäÀÎÁ§ÅÍ´Â ¾Ë·¹¸£±â ¹ßº´·ü Áõ°¡·Î ÀÎÇØ ³ôÀº ¼ö¿ä¸¦ º¸À̰í ÀÖ½À´Ï´Ù. °¢ ±â¾÷µéÀº ÁÖ»ç ½Ã°£ ´ÜÃà, ½Å·Ú¼º, ºñ¿ë È¿À²¼º µîÀÇ ±â´ÉÀ» ÅëÇØ Á¦Ç° Â÷º°È­¿¡ ÁÖ·ÂÇϰí ÀÖÀ¸¸ç, °æÀï ȯ°æÀº ¿ªµ¿ÀûÀÌ°í ºü¸£°Ô ÁøÈ­Çϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¿ÀÅäÀÎÁ§ÅÍ ½ÃÀå °³¿ä

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¿ÀÅäÀÎÁ§ÅÍÀÇ ÁÖ¿ä ½ÃÀå µ¿Çâ

Á¦4Àå ¿ÀÅäÀÎÁ§ÅÍ »ê¾÷ Á¶»ç

Á¦5Àå ¿ÀÅäÀÎÁ§ÅÍ ½ÃÀå : ³ô¾ÆÁö´Â ÁöÁ¤ÇÐÀû ±äÀåÀÇ ¿µÇâ

Á¦6Àå ¿ÀÅäÀÎÁ§ÅÍ ½ÃÀå »óȲ

Á¦7Àå ¿ÀÅäÀÎÁ§ÅÍ ½ÃÀå - Á¦Ç° À¯Çüº°

Á¦8Àå ¿ÀÅäÀÎÁ§ÅÍ ½ÃÀå - ÀûÀÀÁõº°

Á¦9Àå ¿ÀÅäÀÎÁ§ÅÍ ½ÃÀå - ÃÖÁ¾»ç¿ëÀÚº°

Á¦10Àå ¿ÀÅäÀÎÁ§ÅÍ ½ÃÀå - Áö¿ªº°

Á¦11Àå ÁÖ¿ä º¥´õ ºÐ¼® - ¿ÀÅäÀÎÁ§ÅÍ ¾÷°è

Á¦12Àå ¾Ö³Î¸®½ºÆ®ÀÇ Àü¹æÀ§ Àü¸Á

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

REPORT HIGHLIGHT

Auto-Injectors Market size was valued at USD 112,123.21 Billion in 2023, expanding at a CAGR of 12.5% from 2024 to 2032.

Auto-injectors are medical devices designed for the self-administration of injectable drugs. These devices are particularly useful for patients with chronic conditions, such as allergies, rheumatoid arthritis, and multiple sclerosis, allowing for easy and safe administration outside of clinical settings. Auto-injectors provide an efficient, user-friendly alternative to traditional syringes, offering precise dosing and reducing the risk of needle-related injuries. The market for auto-injectors has been growing steadily, driven by the increasing demand for biologics and injectable therapies, as well as advancements in healthcare technologies to improve patient outcomes.

Auto-Injectors Market- Market Dynamics

Rising prevalence of chronic diseases

The auto-injectors market is driven by several key factors, including the rising prevalence of chronic diseases such as diabetes, rheumatoid arthritis, and anaphylaxis, which require frequent self-administration of medications. Advancements in drug delivery technologies, the increasing adoption of home healthcare, and the need for convenient and pain-free injection methods further fuel market growth. Moreover, the growing emphasis on patient-centric solutions and regulatory approvals for advanced auto-injector devices are contributing to the market's expansion. Additionally, the shift toward personalized medicine and a more significant focus on biologics also support the growing demand for auto-injectors in healthcare

Auto-Injectors Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 12.5% over the forecast period (2024-2032)

Based on product type segmentation, disposable auto-injectors were predicted to show maximum market share in the year 2023

Based on Indication segmentation, rheumatoid arthritis was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Auto-Injectors Market- Segmentation Analysis:

The Global Auto-Injectors Market is segmented on the basis of Product Type, Indication, End-User, and Region.The auto-injector market is primarily divided into two segments based on product type: disposable auto-injectors and reusable auto-injectors. Disposable auto-injectors are designed for single-use and are typically preferred for conditions that require emergency treatment or when cost-efficiency is a priority. On the other hand, reusable auto-injectors are built for multiple uses, often used by patients requiring ongoing medication for chronic conditions. The disposable auto-injector segment dominates the market due to its convenience, ease of use, and growing demand for emergency treatments like epinephrine for anaphylaxis.

The auto-injectors market is segmented based on therapeutic indications, including rheumatoid arthritis, multiple sclerosis, diabetes, anaphylaxis, and other therapies. Among these, the rheumatoid arthritis segment dominates, driven by the increasing prevalence of the disease and the effectiveness of biologic treatments delivered through auto-injectors. Multiple sclerosis also holds a significant share, as these devices enable patients to administer treatments at home, offering convenience and reducing hospital visits. The diabetes segment is growing rapidly due to the rise in insulin-dependent patients, while anaphylaxis remains a critical use case, particularly in emergency situations. Overall, the market is expanding with a focus on patient-centric solutions.

Based on end-use the market is segmented as Homecare Settings, Hospitals & Clinics and Ambulatory Surgical Centers. The homecare settings segment dominated the market. Auto-injectors are increasingly popular in homecare settings, as they allow patients to safely and easily administer their medications on their own. This convenience reduces the need for frequent healthcare visits, making treatments more accessible and efficient for individuals managing chronic conditions. The rise of these devices in homecare is a key factor contributing to the segment's rapid growth.

Auto-Injectors Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. In 2023, North America dominated the market, primarily driven by the high prevalence of chronic conditions like diabetes, anaphylaxis, and rheumatoid arthritis. The region benefits from a robust healthcare infrastructure, growing awareness of self-administration of medications, and continuous advancements in drug delivery technologies. Additionally, significant investments in research and development by key market players, along with supportive government policies and substantial healthcare spending, are driving the market's expansion. These factors collectively contribute to North America's leading position in the global auto-injectors market. Europe is experiencing steady growth, supported by the aging population and high demand for emergency treatment solutions. The Asia-Pacific region is emerging as a key player, fueled by the growing healthcare infrastructure, rising awareness, and the increasing prevalence of lifestyle diseases. Latin America and the Middle East & Africa are expected to grow steadily with enhanced healthcare access

Auto-Injectors Market- Competitive Landscape:

The auto-injectors market is characterized by intense competition, driven by several major players such as Mylan, Becton Dickinson, Amgen, and Teva Pharmaceuticals. These companies offer a range of products for conditions such as rheumatoid arthritis, multiple sclerosis, and anaphylaxis. The market is influenced by technological advancements, including the development of user-friendly devices with enhanced safety features. Epinephrine auto-injectors, in particular, have seen strong demand, especially due to rising incidences of allergies. Companies are focusing on improving product differentiation through features like faster injection times, reliability, and cost-effectiveness, making the competitive landscape dynamic and rapidly evolving

Recent Developments:

In March 2024, Ypsomed announced the sale of its insulin pen needle and blood sugar monitoring divisions to MTD Group. This strategic shift will enable Ypsomed to focus on advancing its smart pumps and autoinjector technologies. As part of the transition, Ypsomed plans to invest over USD 111 million to expand its Solothurn site, with job retention guaranteed until the end of 2024. Ypsomed will continue as a contract manufacturer for these operations until mid-2025.

In October 2023, Altaviz launched its AltaVISC auto-injector platform, designed for the efficient delivery of high-volume and high-viscosity biologics. The innovative platform, featuring Pico-cylinders, offers precise drug administration by controlling both temperature and gas composition, making it suitable for various drug formulations, including shear-sensitive molecules. The platform aims to enhance at-home treatment experiences with its cutting-edge technology.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL AUTO-INJECTORS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

GLOBAL AUTO-INJECTORS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

GLOBAL AUTO-INJECTORS MARKET, BY INDICATION- MARKET ANALYSIS, 2019 - 2032

GLOBAL AUTO-INJECTORS MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

GLOBAL AUTO-INJECTORS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

Table of Contents

1. Auto Injectors Market Overview

2. Executive Summary

3. Auto Injectors Key Market Trends

4. Auto Injectors Industry Study

5. Auto Injectors Market: Impact of Escalating Geopolitical Tensions

6. Auto Injectors Market Landscape

7. Auto Injectors Market - By Product Type

8. Auto Injectors Market - By Indication

9. Auto Injectors Market - By End-User

10. Auto Injectors Market- By Geography

11. Key Vendor Analysis- Auto Injectors Industry

12. 360 Degree Analyst View

13. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â